Abbasi Maryam, Ramezani Fatemeh, Elyasi Maryam, Sadeghi-Aliabadi Hojjat, Amanlou Massoud
Department of Medicinal Chemistry, Faculty of Pharmacy, Pharmaceutical Science Research Center, Tehran University of Medical Science, Tehran, Iran.
Department of Medicinal Chemistry, Faculty of Pharmacy, Isfahan University of Medical Sciences, 81746-73461, Isfahan, Iran.
Daru. 2015 Apr 29;23(1):29. doi: 10.1186/s40199-015-0111-z.
MMP-2 enzyme is a kind of matrix metalloproteinases that digests the denatured collagens and gelatins. It is highly involved in the process of tumor invasion and has been considered as a promising target for cancer therapy. The structural requirements of an MMP-2 inhibitor are: (1) a functional group that binds the zinc ion, and (2) a functional group which interacts with the enzyme backbone and the side chains which undergo effective interactions with the enzyme subsites.
In the present study, a QSAR model was generated to screen new inhibitors of MMP-2 based on L-hydroxy tyrosine scaffold. Descriptors generation were done by Hyperchem 8, DRAGON and Gaussian98W programs. SPSS and MATLAB programs have been used for multiple linear regression (MLR) and genetic algorithm partial least squares (GA-PLS) analyses and for theoretical validation. Applicability domain of the model was performed to screen new compounds. The binding site potential of all inhibitors was verified by structure-based docking according to their binding energy and then the best inhibitors were selected.
The best QSAR models in MLR and GA-PLS were reported, with the square correlation coefficient for leave-one-out cross-validation (Q(2) LOO) larger than 0.921 and 0.900 respectively. The created MLR and GA-PLS models indicated the importance of molecular size, degree of branching, flexibility, shape, three-dimensional coordination of different atoms in a molecule in inhibitory activities against MMP-2. The docking study indicated that lipophilic and hydrogen bonding interactions among the inhibitors and the receptor are involved in a ligand-receptor interaction. The oxygen of carbonyl and sulfonyl groups is important for hydrogen bonds of ligand with Leu82 and Ala83. R2 and R3 substituents play a main role in hydrogen bonding interactions. R1 is sited in the hydrophobic pocket. Methylene group can help a ligand to be fitted in the lipophilic pocket, so two methylene groups are better than one. The Phenyl group can create a π-π interaction with Phe86.
The QSAR and docking analyses demonstrated to be helpful tools in the prediction of anti-cancer activities and a guide to the synthesis of new metalloproteinase inhibitors based on L-tyrosine scaffold.
MMP - 2酶是一种能消化变性胶原蛋白和明胶的基质金属蛋白酶。它高度参与肿瘤侵袭过程,被认为是癌症治疗的一个有前景的靶点。MMP - 2抑制剂的结构要求为:(1)一个与锌离子结合的官能团,以及(2)一个与酶主链相互作用且能与酶亚位点进行有效相互作用的侧链的官能团。
在本研究中,基于L - 羟基酪氨酸支架构建了一个定量构效关系(QSAR)模型,用于筛选MMP - 2的新型抑制剂。通过Hyperchem 8、DRAGON和Gaussian98W程序生成描述符。使用SPSS和MATLAB程序进行多元线性回归(MLR)和遗传算法偏最小二乘法(GA - PLS)分析以及理论验证。利用模型的适用域筛选新化合物。根据所有抑制剂的结合能,通过基于结构的对接验证其结合位点潜力,然后选择最佳抑制剂。
报告了MLR和GA - PLS中最佳的QSAR模型,留一法交叉验证的平方相关系数(Q(2) LOO)分别大于0.921和0.900。所构建的MLR和GA - PLS模型表明分子大小、支化程度、柔韧性、形状以及分子中不同原子的三维配位在对MMP - 2的抑制活性中具有重要性。对接研究表明抑制剂与受体之间的亲脂性和氢键相互作用参与配体 - 受体相互作用。羰基和磺酰基的氧对于配体与Leu82和Ala83的氢键形成很重要。R2和R3取代基在氢键相互作用中起主要作用。R1位于疏水口袋中。亚甲基可帮助配体适配到亲脂口袋中,所以两个亚甲基比一个更好。苯基可与Phe86形成π - π相互作用。
QSAR和对接分析被证明是预测抗癌活性的有用工具,也是基于L - 酪氨酸支架合成新型金属蛋白酶抑制剂的指南。